Oral combination therapy for type 2 diabetes
- 24 September 2002
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 18 (S3) , S70-S76
- https://doi.org/10.1002/dmrr.278
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- PioglitazoneDrugs, 2000
- Therapeutic objectives and their practical achievement in type 2 diabetesJournal of Diabetes and its Complications, 2000
- Combining sulfonylureas and other oral agentsThe American Journal of Medicine, 2000
- Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetesDiabetologia, 2000
- Pharmacologic Therapy for Type 2 Diabetes MellitusAnnals of Internal Medicine, 1999
- RosiglitazoneDrugs, 1999
- Improving glycaemic control with current therapiesDiabetic Medicine, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Oral AntihyperglycaemicsDrugs & Aging, 1997
- Management of Non‐insulin‐dependent Diabetes Mellitus in Europe: A Concensus ViewDiabetic Medicine, 1988